跳至主要内容
临床试验/CTRI/2025/10/096288
CTRI/2025/10/096288尚未招募2 期

A clinical study of Rajanyadi Churna in the management of Pandu Roga with special reference to Iron Deficiency Anemia in Children.

Gunjal Priya1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年12月1日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Improvement in the clinical signs and symptoms of Pandu Roga (Iron Deficiency Anemia) and increase in hemoglobin level after taking Rajanyadi Churna.

研究概览

简要总结

The present clinical study is designed to evaluate the efficacy and safety of Rajanyadi Churna in the management of Pandu Roga with special reference to Iron Deficiency Anemia in children. Pandu Roga described in Ayurveda closely resembles Iron Deficiency Anemia in modern medicine, characterized by pallor, fatigue, weakness, and poor appetite.In this study, children diagnosed with Pandu Roga will be selected based on specific inclusion and exclusion criteria. Rajanyadi Churna, a classical Ayurvedic formulation containing herbs with Deepana, Pachana, Raktavardhaka and Balya properties, will be administered in appropriate pediatric dosage for 60 days.The assessment will be carried out on both subjective parameters such as pallor, weakness, and appetite, and objective parameters including hemoglobin level, RBC count, serum iron, and hematocrit values. The outcomes will be compared before and after treatment to evaluate the effectiveness of Rajanyadi Churna in improving hematological status and overall health of children suffering from Pandu Roga.

This study aims to provide scientific validation to the traditional Ayurvedic approach in managing Iron Deficiency Anemia and to establish Rajanyadi Churna as a safe and effective formulation for pediatric use.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
1.00 Year(s) 至 16.00 Year(s)(—)
性别
All

入选标准

  • Patients of either sex from age 1 to 16 years.
  • Children with haemoglobin level more than 6 gm/dl and less than 11gm/dl.

排除标准

  • Haemoglobin level less than 6gm/dl.
  • Patient having occult blood positive on stool examination.
  • Children having severe diseases like HIV, Tuberculosis, Juvenile diabetes and cardiac patient, any other type of anemia except IDA.
  • IDA with any associated severe complication.

结局指标

主要结局

Improvement in the clinical signs and symptoms of Pandu Roga (Iron Deficiency Anemia) and increase in hemoglobin level after taking Rajanyadi Churna.

时间窗: Baseline and after 60 Days of treatment.

次要结局

  • Improvement in hemotological parameters (RBC, Hb%, Hematocrit) and overall physicall well being.(Baseline and after 60 Days of treatment.)

研究者

发起方
Gunjal Priya
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Gunjal Priya

Government Ayurvedic College and Hospital, Patna

研究点 (1)

Loading locations...

相似试验